• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of major national dementia policies and health-care system preparedness for early medical action and implementation.评估主要国家的痴呆症政策和卫生保健系统,为早期医疗行动和实施做好准备。
Alzheimers Dement. 2022 Oct;18(10):1993-2002. doi: 10.1002/alz.12655. Epub 2022 Mar 16.
2
Cost of disorders of the brain in Europe 2010.2010 年欧洲大脑疾病负担成本。
Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15.
3
Tuberculosis结核病
4
[Evolution and new perspectives of health care financing in developing countries].[发展中国家医疗保健融资的演变与新视角]
Sante. 2003 Oct-Dec;13(4):209-14.
5
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
6
Health-economic burden of dementia in South Korea.韩国痴呆症的健康经济负担。
BMC Geriatr. 2021 Oct 13;21(1):549. doi: 10.1186/s12877-021-02526-x.
7
Features of the Japanese national dementia strategy in comparison with international dementia policies: How should a national dementia policy interact with the public health- and social-care systems?日本国家痴呆症战略的特点与国际痴呆症政策比较:国家痴呆症政策应如何与公共卫生和社会保健系统相互作用?
Alzheimers Dement. 2014 Jul;10(4):468-476.e3. doi: 10.1016/j.jalz.2013.06.005. Epub 2013 Aug 15.
8
How is migration background considered in the treatment and care of people? A comparison of national dementia care guidelines in Europe.在治疗和护理人群时如何考虑移民背景?对欧洲国家痴呆症护理指南的比较。
BMC Public Health. 2020 Oct 15;20(1):1555. doi: 10.1186/s12889-020-09668-4.
9
The recent decline in prevalence of dementia in developed countries: implications for prevention in the Republic of Korea.发达国家近期痴呆症患病率的下降:对韩国预防工作的启示。
J Korean Med Sci. 2014 Jul;29(7):913-8. doi: 10.3346/jkms.2014.29.7.913. Epub 2014 Jul 11.
10
Intersectoral Policy Priorities for Health卫生领域的跨部门政策优先事项

引用本文的文献

1
Bridging Health Disparity Gaps in Alzheimer's Disease among Marginalized Populations: Clinical Proteomics as a Case Study.弥合边缘化人群中阿尔茨海默病的健康差距:以临床蛋白质组学为例
ACS Bio Med Chem Au. 2025 Jul 8;5(4):505-518. doi: 10.1021/acsbiomedchemau.5c00074. eCollection 2025 Aug 20.
2
Neighborhood social cohesion and Alzheimer's disease dementia risk in South Asians in the United States.美国南亚裔社区社会凝聚力与阿尔茨海默病痴呆风险
Alzheimers Dement Behav Socioecon Aging. 2025 Jun;1(2). doi: 10.1002/bsa3.70023. Epub 2025 Jun 24.
3
The Longitudinal Association Between Chronic Back Pain and Cognitive Decline in Older Adults With Mediation Analysis: An Analysis of Four Population-Based Databases.老年人慢性背痛与认知衰退的纵向关联及中介分析:基于四个群体数据库的分析
Eur J Pain. 2025 Sep;29(8):e70084. doi: 10.1002/ejp.70084.
4
Age-sex differences in Alzheimer's and related dementias burden and risk factors in east and Southeast Asia: results from the 2021 GBD study.东亚和东南亚地区阿尔茨海默病及相关痴呆症负担和风险因素的年龄性别差异:2021年全球疾病负担研究结果
Front Aging Neurosci. 2025 Jun 27;17:1562148. doi: 10.3389/fnagi.2025.1562148. eCollection 2025.
5
Geographic Distribution and Future Projections of Mild Cognitive Impairment and Dementia in Greece: Analysis from 1991 to 2050.希腊轻度认知障碍和痴呆症的地理分布及未来预测:1991年至2050年的分析
Brain Sci. 2025 Jun 19;15(6):661. doi: 10.3390/brainsci15060661.
6
Rehd. leaves aqueous extract inhibits learning and memory impairment in Alzheimer's disease rats: Involvement of the SIRT6/NLRP3 signaling pathway.Rehd.叶水提取物可抑制阿尔茨海默病大鼠的学习和记忆障碍:SIRT6/NLRP3信号通路的参与
Ibrain. 2024 Jun 3;11(2):228-244. doi: 10.1002/ibra.12164. eCollection 2025 Summer.
7
Improved dementia screening for elderly with low education in South Korea using the Cognitive Impairment Screening Test (CIST).在韩国,使用认知障碍筛查测试(CIST)改善对低学历老年人的痴呆筛查。
Front Neurosci. 2025 May 14;19:1599019. doi: 10.3389/fnins.2025.1599019. eCollection 2025.
8
Evolution of strategic framework of policies related to dementia care and prevention in China from 2000 to 2024.2000年至2024年中国痴呆症护理与预防相关政策战略框架的演变
Lancet Reg Health West Pac. 2025 May 3;58:101561. doi: 10.1016/j.lanwpc.2025.101561. eCollection 2025 May.
9
Stakeholder perceptions of dementia in Colombia: a qualitative study.哥伦比亚利益相关者对痴呆症的认知:一项定性研究。
BMC Public Health. 2025 Mar 11;25(1):959. doi: 10.1186/s12889-025-22166-9.
10
Tailoring implementation strategies for the healthy actions and lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program: Lessons learned from a survey study.为“避免痴呆的健康行动与生活方式”及“西班牙裔与阿尔茨海默病预防计划”量身定制实施策略:一项调查研究的经验教训
J Prev Alzheimers Dis. 2025 Mar;12(3):100053. doi: 10.1016/j.tjpad.2024.100053. Epub 2025 Jan 17.

本文引用的文献

1
Polygenic Risk Scores in Alzheimer's Disease: Current Applications and Future Directions.阿尔茨海默病的多基因风险评分:当前应用与未来方向
Front Digit Health. 2020 Aug 11;2:14. doi: 10.3389/fdgth.2020.00014. eCollection 2020.
2
A microRNA signature that correlates with cognition and is a target against cognitive decline.与认知相关且可作为对抗认知能力下降的靶点的 microRNA 特征。
EMBO Mol Med. 2021 Nov 8;13(11):e13659. doi: 10.15252/emmm.202013659. Epub 2021 Oct 11.
3
Expected wait times for access to a disease-modifying Alzheimer's treatment in the United States.美国获得阿尔茨海默病修饰治疗的预期等待时间。
Alzheimers Dement. 2022 May;18(5):1071-1074. doi: 10.1002/alz.12470. Epub 2021 Sep 27.
4
The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis.PrecivityAD™ 测试:用于定量检测血浆淀粉样蛋白β 40 和 42 以及载脂蛋白 E 蛋白型的准确可靠的 LC-MS/MS 分析方法,用于评估脑淀粉样变性。
Clin Chim Acta. 2021 Aug;519:267-275. doi: 10.1016/j.cca.2021.05.011. Epub 2021 May 17.
5
Coronavirus Disease 2019 and Dementia: Recommendation of the Korean Dementia Association.2019冠状病毒病与痴呆症:韩国痴呆症协会的建议
Dement Neurocogn Disord. 2020 Dec;19(4):125-128. doi: 10.12779/dnd.2020.19.4.125.
6
Sectoral segmentation of retinal amyloid imaging in subjects with cognitive decline.认知功能减退受试者视网膜淀粉样蛋白成像的扇形分割
Alzheimers Dement (Amst). 2020 Sep 28;12(1):e12109. doi: 10.1002/dad2.12109. eCollection 2020.
7
Current and evolving treatment strategies for the Alzheimer disease continuum.阿尔茨海默病连续体的当前和不断发展的治疗策略。
Am J Manag Care. 2020 Aug;26(8 Suppl):S167-S176. doi: 10.37765/ajmc.2020.88481.
8
Blood-based biomarkers for Alzheimer's pathology and the diagnostic process for a disease-modifying treatment: Projecting the impact on the cost and wait times.用于阿尔茨海默病病理学的血液生物标志物及疾病修饰治疗的诊断流程:预测对成本和等待时间的影响
Alzheimers Dement (Amst). 2020 Aug 18;12(1):e12081. doi: 10.1002/dad2.12081. eCollection 2020.
9
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.《痴呆症的预防、干预与照护:柳叶刀委员会2020年报告》
Lancet. 2020 Aug 8;396(10248):413-446. doi: 10.1016/S0140-6736(20)30367-6. Epub 2020 Jul 30.
10
World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia.世界范围内 FINGERS 网络:降低痴呆风险和预防痴呆的全球方法。
Alzheimers Dement. 2020 Jul;16(7):1078-1094. doi: 10.1002/alz.12123. Epub 2020 Jul 5.

评估主要国家的痴呆症政策和卫生保健系统,为早期医疗行动和实施做好准备。

Evaluation of major national dementia policies and health-care system preparedness for early medical action and implementation.

机构信息

Neurology Business Group, Eisai Inc., Nutley, New Jersey, USA.

University of Tokyo, Tokyo, Japan.

出版信息

Alzheimers Dement. 2022 Oct;18(10):1993-2002. doi: 10.1002/alz.12655. Epub 2022 Mar 16.

DOI:10.1002/alz.12655
PMID:35293672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9790361/
Abstract

With population growth and aging, the number of people with dementia and related disorders will grow substantially in the years ahead, bringing with it significant societal, health-care, and economic challenges. Here, we analyze dementia policies of seven major countries in Asia/Pacific, Europe, and North America to identify opportunities for early actions to mitigate disease burden. We find that most countries are addressing this need by including a specific focus on early action in their national dementia strategies (five of seven countries), implementing public health initiatives for risk reduction, prevention, and early detection and diagnosis (six of seven countries); supporting enabling research for early detection and risk reduction (six of seven countries); and enacting a system for early, regular brain health screening (one of seven). We discuss risks and opportunities for integrating early action policies and conducting additional systematic research to understand the potential benefits and impacts of these policies.

摘要

随着人口增长和老龄化,未来几年痴呆症和相关疾病患者的数量将大幅增加,这将带来重大的社会、医疗保健和经济挑战。在这里,我们分析了亚太地区、欧洲和北美的七个主要国家的痴呆症政策,以确定采取早期行动减轻疾病负担的机会。我们发现,大多数国家正在通过在国家痴呆症战略中特别关注早期行动(七个国家中的五个)、实施降低风险、预防、早期发现和诊断的公共卫生倡议(七个国家中的六个)、支持早期发现和降低风险的开拓性研究(七个国家中的六个)以及制定早期、定期的大脑健康筛查系统(七个国家中的一个)来满足这一需求。我们讨论了整合早期行动政策和进行额外系统研究的风险和机会,以了解这些政策的潜在好处和影响。